INC Research Integrates DrugDev's SiteCloud Platform
INC Research announced a strategic collaboration with DrugDev to complete integration with and implementation of DrugDev’s SiteCloud platform.
INC Research announced a strategic collaboration with DrugDev to complete integration with and implementation of DrugDev’s SiteCloud platform. The SiteCloud platform is the same technology used by TransCelerate’s Investigator Registry and the Investigator Databank. Using a universal identifier within the platform allows INC to match data from numerous disparate sources--such as its internal experience, the DrugDev Network of 80,000 opted-in global investigators across 115 countries and trusted third-party resources--to create a virtual private database for INC with site and investigator profiles that will be used to make evidence-based decisions.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
